ChoA Pharmaceutical

조아제약 · 034940

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$15M (₩20.7B)

Overview

ChoA Pharmaceutical makes medicines and health-care products supplied to patients and health-care providers in South Korea.

The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. The filing's table of contents covers a broad range of pharmaceutical products and services, along with active research and development activity, suggesting the business spans both established drug lines and pipeline work.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$43M

▼ −5.4% YoY

Operating profit · FY2025

−US$4.8M

Loss narrowed

Net income · FY2025

−US$5.3M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$45.6M(₩63B)	US$45.4M(₩62.7B)	US$43M(₩59.3B)
Operating profit	−US$5M(−₩6.8B)	−US$7M(−₩9.6B)	−US$4.8M(−₩6.6B)
Net income	−US$8.1M(−₩11.1B)	−US$7.4M(−₩10.2B)	−US$5.3M(−₩7.4B)

Revenue

FY2023US$45.6M
FY2024US$45.4M
FY2025US$43M

Operating profit

FY2023−US$5M
FY2024−US$7M
FY2025−US$4.8M

Net income

FY2023−US$8.1M
FY2024−US$7.4M
FY2025−US$5.3M

Key ratios (FY2025)

ROE

-33.8%

Debt/Eq

197.2%

Op. margin

-11.1%

Net margin

-12.4%

Rev. YoY

▼ −5.4%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?